Faienza, M.F.; Tummolo, A.; Celli, M.; Finocchiaro, R.; Piacente, L.; Di Serio, F.; Nicchia, G.P.; Brunetti, G.; D’Eufemia, P.
Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1. Biomedicines 2023, 11, 458.
https://doi.org/10.3390/biomedicines11020458
AMA Style
Faienza MF, Tummolo A, Celli M, Finocchiaro R, Piacente L, Di Serio F, Nicchia GP, Brunetti G, D’Eufemia P.
Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1. Biomedicines. 2023; 11(2):458.
https://doi.org/10.3390/biomedicines11020458
Chicago/Turabian Style
Faienza, Maria Felicia, Albina Tummolo, Mauro Celli, Roberto Finocchiaro, Laura Piacente, Francesca Di Serio, Grazia Paola Nicchia, Giacomina Brunetti, and Patrizia D’Eufemia.
2023. "Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1" Biomedicines 11, no. 2: 458.
https://doi.org/10.3390/biomedicines11020458
APA Style
Faienza, M. F., Tummolo, A., Celli, M., Finocchiaro, R., Piacente, L., Di Serio, F., Nicchia, G. P., Brunetti, G., & D’Eufemia, P.
(2023). Brain-Type Creatine Kinase Release from Cultured Osteoclasts Exposed to Neridronate in Children Affected by Osteogenesis Imperfecta Type 1. Biomedicines, 11(2), 458.
https://doi.org/10.3390/biomedicines11020458
